Skip to main content
. 2019 Jul 11;11(7):972. doi: 10.3390/cancers11070972

Figure 7.

Figure 7

RH1 resistant cells acquire insusceptibility to conventional chemotherapy drugs, but not to c-KIT-targeted therapy. MDA-P and MDA-R cells were treated with increasing concentrations of drugs for 48 h: (A) docetaxel; (B) 5-fluorouracil; (C) oxaliplatin; (D) epirubicin; or for 72 h for (E) masitinib. Cell viability was measured after 96 h using the MTT assay. The results are the mean of 3 independent experiments; bars are ± SD (ANOVA; * p < 0.05; ** p < 0.01).